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Background: During the COVID-19 pandemic people are facing risks of adverse health
effects due to the restrictions implemented such as quarantine measures, reduced
social contact, and self-isolation. In this qualitative review, we collected data on potential
preventive and therapeutic health benefits of Complementary and Integrative Medicine
(CIM) that might be useful during the COVID-19 pandemic. We have reviewed the
scientific literature to summarize CIM practices that could be beneficial for improving
physical and mental health and well-being of the population under the current pandemic
circumstances. It must be noted that this review is not SARS-CoV-2 specific and we
explicitly do not intend to make any SARS-CoV-2 specific health claims in this article.
Methods and Findings: A qualitative, non-systematic literature review was conducted
in Medline to identify literature describing preventive and therapeutic CIM approaches
for strengthening mental and physical health. For a variety of CIM approaches
clinical evidence was identified, indicating beneficial effects. CIM approaches include
specific dietary measures and selected micronutrients, physical activity, techniques from
Mind-Body Medicine, single botanicals or botanical compounds, and spending time
in nature among others. The effects of CIM measures on conditions like obesity and
hypertension are of special relevance here, as these conditions are considered as risk
factors for a severe course of COVID-19. Moreover, a possibly direct effect of CIM
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approaches on immune functions and clinical parameters in respiratory tract infections,
such as influenza, were identified. The findings of this review could be helpful for clinicians,
patients, and the general population during the current pandemic when discussing
and/or considering CIM options.
Conclusions: CIM offers a variety of preventive and therapeutic options for
strengthening physical and mental resilience, which could also be useful in the current
COVID-19 pandemic. The evidence of CIM approaches with a potential benefit in the
COVID-19 pandemic in different areas is worth to be analyzed. While this qualitative
review has several obvious limitations, it might serve as useful starting point for further
research on this topic.
Keywords: COVID-19, integrative medicine, complementary medicine, SARS-CoV-2, traditional medicine systems,
phytomedicine, botanicals, mind-body medicine
INTRODUCTION
With the COVID-19 pandemic, mankind is facing a global health
threat for which no specific therapy has yet been scientifically
established. Worldwide, more than 46 million infections and
1.2 million deaths related to SARS-CoV-2 had occurred by the
end of October 2020 (1). The COVID-19 pandemic as well
as previous viral epi- and pandemic threats such as severe
acute respiratory syndrome (SARS), Middle East respiratory
syndrome (MERS), Ebola virus disease and swine flu warrant the
assumption that such agents will continue to threaten health care
systems, societies and economies worldwide (2, 3).
Individual lifestyles not only affect overall health and well-
being, but can also affect related personal risk factors to the extent
that they can contribute to the spread and negative consequences
of communicable diseases (CD) (4, 5). Besides, nutrition and
lifestyle of individuals and populations can potentially affect
environmental sustainability and human health (6). While the
main focus during a pandemic such as SARS-CoV-2 is on causal
factors for the virus, both the physical and mental health of
individuals and the population are also important, especially for
those with risk factors (7).
The most commonly identified relevant risk factors for
a severe course of the COVID-19 disease in intensive care
unit (ICU) patients, are hypertension (48% non-survivors vs.
23% survivors), diabetes mellitus (31 vs. 14%), coronary heart
disease (24 vs. 1%), chronic obstructive pulmonary disease (7
vs. 1%), and renal dysfunction (4 vs. 0%) (7). Here, CIM
approaches may mitigate the aforementioned risk factors by
fostering resilience, self-efficacy/self-empowerment, and other
health-related resources of the individual facing the current
health challenge (8).
Although lockdowns are an important safety measure to
protect public health, several cross-sectional studies showed that
they can lead to a variety of negative lifestyle changes including
lack of exercise, “unhealthy” eating patterns, sleep disorders,
and psychological symptoms including anxiety and depression
(9, 10).
The fact that a vaccine against SARS-CoV-2 or a specific
cure for COVID-19 is not yet available makes it necessary to
explore how current preventive and therapeutic gaps could be
bridged with Complementary and Integrative Medicine (CIM)
interventions. Evidence-based CIM approaches, such as Mind-
Body Medicine, nutritional medicine, phytomedicine, could
complement, and personalize conventional medical strategies as
part of overall health care management (11, 12).
CIM practices generally emphasize a holistic, patient-centered
approach to health, healthcare, and well-being—often including
psycho-emotional, functional, social, and even spiritual aspects
(11, 12). There is a noteworthy body of CIM knowledge that
has evolved over centuries, which has been used to prevent and
manage a variety of diseases and is being increasingly used in
health care systems worldwide (13)—also in so-called Traditional
Medicine Systems (TMS). The World Health Organization
(WHO) emphasizes the role of Traditional Medicine as a medical
heritage “to promote universal health coverage by integrating
traditional and complementary medicine services into health
care service delivery and self-health care” (14). In international
scientific handling, TMS are mainly subsumed under CIM.
The complex interrelationships between the immune system
and a variety of lifestyle factors such as exercise, stress reduction,
healthy nutrition, spending time in nature, positive inner
attitudes, and well-being have already been demonstrated (15–
20). In spite of the challenges faced by people across the globe
due to restrictive lifestyle factors such as social distancing and
quarantine measures, the general public and patients could
utilize this time of forced domestic retreat of varying degrees to
strengthen resilience through simple preventive means and self-
care. Thus, CIMmeasures could be used to improve quality of life
in an extraordinary situation such as the COVID-19 crisis that
causes stress, fear, anxiety and depression amongst individuals
and societies worldwide (8).
The findings of this review are not intended to serve as
alternative recommendations to official public health measures
or conventional medical advice. They should be understood as
simple and effective, preferably evidence-based tools that may
complement global disease control measures and mainstream
treatment strategies. At the same time, there is a worldwide
tendency even among national governments, to ignore and/or
reject scientific data on coronavirus and COVID-19, combined
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with the proliferation of related unfounded and specific health
claims. Therefore, the authors explicitly want to emphasize that
the results presented in this article are not SARS-CoV-2-virus
specific and that no COVID-19-specific CIM claims can be made
based on the current evidence-base.
METHODS
A literature review in the electronic database “Medline” was
carried out on July 24, 2020 and updated on October 29, 2020.
Four authors (GS, MJ, AM, CK) have selected potential CIM
interventions in a consensus process that could be useful in
strengthening mental and physical health during the COVID-19
pandemic. Based on this the search strategy included the terms
“complementary,” “integrative,” “traditional,” “medicine,” “CIM,”
“CAM,” “stress,” “mind-body-medicine,” “meditation,” “yoga,”
“qi gong,” “tai chi,” “phytomedicine,” “botanical medicine,”
“positive wellbeing,” “optimism,” “resilience,” “virus,” “virus
infection,” and “COVID-19” separately or combined by Boolean
Operators. Relevant meta-analyses and original articles including
prospective trials, epidemiological population-based studies and
retrospective analysis, reviews and guidelines were included.
Publications in English and German were included.
RESULTS
A large variety of studies, interventions, outcomes, studied
sample sizes, treatment durations, and observation times were
identified. According to the studies reviewed, CIM interventions
appear to strengthen physical and mental health through:
(1) nutrition and vitamin supplementation, (2) Mind-Body
Medicine, (3) positive attitude of life and relationships, (4)
exercise, (5) nature therapy, (6) aroma therapy, (7) sleep
medicine, and (8) botanicals/phytomedicine. These topics are
partly covered in so-called Traditional Medicine Systems (TMS).
Relevant points are presented in detail below:
Nutrition and Vitamin Supplementation
Nutrition
Nutrition is currently discussed not only as a game changer for
planetary health (21) and the ongoing current climate crisis (22),
but also as a potential source and reservoir for the emergence of
viruses such as Ebola, MERS, SARS (23), and the development
of multi-resistant bacteria (24) due to factory farming (25, 26)
and wild animal markets (23). In contrast to the adverse effects of
unhealthy food on health, specific diets, rich in antioxidants and
anti-inflammatory nutrients, can have a significant impact with
regard to disease prevention/management and longevity (27, 28).
Such an influence of nutrition on health is particularly
important for older people, as eating habits that contain macro-
and micronutrients as well as phytochemicals can have a
positive influence on health (29). Above all nutrition can play a
major role in the “individual susceptibility” to bacterial or viral
infections and, if infected, in the course and outcome of the
infectious disease.
Hypo- as well as hyper-caloric nutritional status, alongside
certain micronutrient deficiencies have been identified as risk
factors for susceptibility to infections (30). During the COVID-19
pandemic, older adults and patients with chronic diseases became
particularly vulnerable and most at risk to nutrition imbalance
(31). In the context of COVID-19, several position papers
and suggestions for clinical investigation have been published;
however, little observational data are available yet (31–34).
An optimized nutritional status can have a range of positive
effects on the immune system (35). A predominantly plant-based
diet, including e.g., fruits, vegetables, legumes, nuts, and olive
oil, may have an influence on the susceptibility to infectious
diseases; particularly foods containing potentially antimicrobial,
antioxidant, anti-inflammatory, and immunomodulatory
phytochemicals, such as bitter substances, vitamin C, mustard
oils, herbs and spices, and herbal teas (19).
Nutrition, particularly when optimized for nutrient
proportions, predominantly plant-based and organic (36),
can exert relevant anti-inflammatory effects (37) and may have a
long-term impact on general health and NCDs such as obesity,
hypertension, and cancer (38, 39). There is growing evidence
for negative correlations between plant-based nutrition, chronic
inflammation (40), and pathological immune responses such as
in bronchial asthma (41). A meta-analysis including 29 RCTs
with 2.689 participants consumption of plant-based diets was
associated with a reduction in the mean concentrations of CRP
[effect size, −0.55 mg/l, 95% confidence intervals (CI): −0.78;
−0.32, I2 = 94.4%] and IL-6 [effect size, −0.25 ng/l, 95% CI:
−0.56; 0.06, I2 = 74%] (37).
NCDs predispose the individual to reduced immunity (40,
42), whereas enhanced nutrition protects from susceptibility to
infectious agents; for example, a 5% higher proportional intake of
fruit and vegetables is associated with a 12% lower hospitalization
due to influenza infections (43), a lower risk of infection due to
Mycobacterium tuberculosis exposure (44), and a lower frequency
of urinary tract infections in pregnant women (45). Furthermore,
the effectiveness of vaccinationmay be higher when the plant part
of the diet increases (46).
In a recent systematic review, vitamins A and D showed
a potential benefit in viral respiratory infections, especially in
deficient populations (47). Among the trace elements, selenium
and zinc have also shown beneficial immunomodulatory effects
in viral respiratory infections (47). Although the nutritional
status of patients with COVID-19 has not yet been adequately
studied, there is preliminary evidence that nutrient-related
disorders are associated with poorer disease progression and
outbreak, probably associated with greater susceptibility to
infection (48).
In the following, we would like to go into more detail about
the vitamins D and C:
Vitamin D
Vitamin D3 has crucial influence on many functions of the
immune system (49). In a randomized controlled trial (RCT)
with supplementation of 400 IU/d, improvements of serum 25-
hydroxyvitamin D concentrations were associated with at least
a 1.5-fold alteration in the expression of 291 genes, many with
relation to immune cell function and inflammatory control (50).
Of potential clinical importance, vitamin D deficiency has been
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associated with increased prevalence of different viral conditions
such as human immunodeficiency virus and hepatitis C. The
role of vitamin D in influenza has remained controversial (51),
although there are preventive studies that show lower incidences
when supplements are given in schoolchildren (52). In this
RCT Influenza A occurred in 18 of 167 (10.8%) children in the
vitamin D group compared with 31 of 167 (18.6%) children
in the placebo group [relative risk (RR), 0.58; 95% CI: 0.34,
0.99; P = 0.04]. A recent meta-analysis of 25 RCTs including
11.321 participants for vitamin D supplementation in respiratory
tract infections, most of them assumed or proven to be viral,
revealed a homogeneous risk reduction among all participants
(adjusted odds ratio 0.88, 95% confidence interval 0.81–0.96; p
for heterogeneity <0.001) (53).
Vitamin D3 deficiency has been shown to be a risk factor for
the onset of acute respiratory distress syndrome (ARDS) (54).
In the context of COVID-19 a recent retrospective population-
based study in Israel showed an association between vitamin D
deficiency and greater likelihood of both COVID-19 infection
and hospitalization in 14,000 analyzed individuals (55). In
contrast, another study analyzed data from 348.958 individuals
in the United Kingdom and found no association between
vitamin D levels and COVID-19 infection. Future (especially
randomized) studies are warranted to clarify the effects of vitamin
D supplementation in the context of COVID-19 infection.
A serum concentration of vitamin D3 (25-OH) of at least
20 ng/ml is considered to be sufficient for bone health. In a
preventive setting for infectious diseases, an increased dose of
40–60 ng/mL (corr. 100–150 nmol/L) is recommended.
Vitamin C
In a systematic review of 31 RCTs with at least 0.2 g/d of orally
administered vitamin C for the prevention of common colds,
the incidence could not be reduced under normal conditions,
some benefit was observed in the form of a reduction in
the duration and/or severity of symptoms (56). However, five
RCTs under conditions of unusual physical and/or thermal
stress with above average performing participants demonstrated
homogenous benefits with a pooled risk-ratio (RR) of 0.48
(56). This could be a model for long-term preventive use in
reducing the incidence or severity of manifestation of COVID-
19. Recently, a review concluded that oral vitamin C may reduce
the duration of acute respiratory viral infections symptoms
including fever, chest pain, chills and bodily aches and pains (57).
More recent clinical research on vitamin C has focused on
higher doses, at times given intravenously, e.g., in intensive care
medicine/intensive care unit (ICU). In a pooled analysis of 18
RCTs, length of ventilation, when necessary, and durations of
overall stays in the ICU, mostly for cardiac reasons, were reduced
(58). When shortening of ventilation was considered, eight RCTs
with cardiac and septic indications gave a pooled reduction of
14% for all patients, or of 25% if ventilation was >10 h (59). In
a RCT with patients with sepsis and ARDS, comparable to the
situation with COVID-19 pneumonia, there was a difference in
survival at day 28 of 17% in favor of vitamin C, but this was
only a secondary parameter (60). On the other hand, a recently
published RCT showed that treatment with intravenous vitamin
C in intensive care patients with septic shock did not significantly
improve the duration of time alive and free of vasopressor
administration over 7 days (61). Ongoing RCTs are currently
investigating the effects of intravenous high-dose vitamin C in
the treatment of severe COVID-19 diseases [e.g., (62)].
Mind-Body Medicine (MBM)
MBM is based on the assumption that interactions between the
brain, mind, body, and behavior can be used to activate health-
promoting pathways (63). It includes behavioral approaches and
techniques in conjunction with exercise, relaxation, meditation,
and stress-regulation interventions (63, 64). MBM has been
shown to improve psychological parameters, reduce individual
and cellular stress, inflammation, improve immune function,
involving epigenetic pathways, thereby facilitating self- and
autoregulation, and resilience in general (65–68).
The impact of psychological and behavioral parameters on
health is particularly important in vulnerable phases of life such
as childhood and old age (69) or in challenging situations (70).
Psychological stress for example can lead to an increased
susceptibility to viral infections of the upper airways (71). The
influence of chronic stress on health is enormous (66, 72).
Both CIM and stress research make a clear distinction between
the effects of chronic stress and acute—but moderate—stress
on health (70). Even in positively perceived stress, the dose,
and duration of such stress plays an important role, since
even positively evaluated permanent stress may result in health
risks (70).
Several CIM interventions could be useful in the field of stress
reduction in a pandemic, e.g., using mindfulness, compassion,
yoga, and meditation practices (15–17). The influence of
psychological processes as well as psychological and behavioral
interventions on the immune system (16, 66, 73, 74), positive
psychological well-being (75), physiological functions (76, 77)
as well as the mind’s impact on chronic diseases is quite well-
researched (78).
It is known that MBM therapies can have a positive influence
on inflammatory activity and virus-specific immune responses
(79). A finding that may be of particular interest in the context
of the current pandemic is a possibly improved antibody
response through meditation in persons with chronic stress,
immunocompromised persons and older adults. Antibodies
were measured directly in three studies (80–82), two of which
examined the antibody response to influenza vaccination (82);
one showed that mindfulness-based stress reduction (MBSR)
resulted in a significantly greater increase in hemagglutination-
inhibition influenza antibody titers (80). The second study
showed no relevant changes in serum influenza antibodies or
nasal Immunoglobulin A (IgA) in older adults. In a third
study in older adults with administration of the keyhole limpet
hemocyanin antigen, there was a relatively larger increase
in Immunoglobulin G (IgG) immediately following a MBSR
intervention (81).
Literature on meditation as a method for stress reduction
shows relevant potential for application in the current pandemic
(76, 77). A randomized study showed that MBSR may be a novel
treatment approach for reducing social risk factors like loneliness
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as well as like molecular pro-inflammatory gene expression in
older adults (83). In general, meditation seem to have a potential
for inflammation reduction, including gene expression, cellular
and chromosomal health (84). This also includes self-regulation
and self-healing capacities, i.e., the innate restorative capacities of
mind and body (64).
In addition, several other MBM interventions showed
beneficial effects. Yoga has been shown to increase several
parameters of the immune function (74), as well as reduce
several COVID-19 associated risk factors, including hypertension
(85), obesity (86), further cardiovascular risk factors (87) or
chronic obstructive pulmonary disease. Yoga and meditation
are discussed in this context—also from the perspective of
Traditional Indian Medicine (TIM)—as a potentially effective
tool in the context of the current pandemic because of its global
popularity (88–90).
Also qigong is supported by a growing body of scientific
evidence (91, 92). A meta-analysis on qigong demonstrates the
effectiveness of qigong in improving cardiovascular risk factors
in participants with metabolic syndrome (91).
Complex MBM-trainings that include relaxation,
nutritional counseling, and exercise within the framework
of a multimodality group program can positively influence
cardiovascular risk factors for COVID-19 such as atherosclerosis
and systolic blood pressure (93).
Further studies on CIM interventions in the field of MBM
are warranted in the current pandemic, possibly taught via
online courses.
Positive Attitude to Life
Psychological stress has been found to lead to a significantly
and dose-dependently higher infection rate with coronavirus
type 229E and other seasonal pathogens (94). Emotional state
may therefore be an important variable in the immune defense.
A number of large epidemiological studies show the protective
influence of a positive attitude toward life in chronic non-
communicable diseases and further studies show that chronic
stress is associated with detrimental outcomes in many health
conditions (94). Positive psychological well-being does not only
seem to be crucial for several cardiovascular issues, but for
resilience in a broader sense (75). When life becomes meaningful
and positive, it reduces the risk factors for chronic heart
disease (75) and hypertension (95) by reducing high levels of
stress hormones (96). A positive attitude toward life can have
significant effects on survival in healthy and sick people (97).
Furthermore, a positive attitude to life is associated with a lower
risk of cardiovascular events and all-cause mortality (98).
Relationships
Relationships are important variables for health and survival
in a variety of diseases (99). Isolation and loneliness, feelings
that are likely to result from quarantine (situations) (100),
which may in turn exert significant negative influence on
specific physiological parameters (73, 101) such as immune
functions (102) and are equally detrimental to the health as
that of smoking (103). Particularly in a situation of increased
insecurity such as a pandemic, where social contacts have
negative connotations, strengthening social relationships (100)—
possibly also via outdoor and online services can be important.
In general, maintain strong relationships may lead to better
objective health status and perceptions of health (99).
Exercise
The positive effects of exercise for general mental and physical
health as well as for specific physiological functions including the
immune system have been demonstrated in several systematic
reviews and meta-analyses (18). Lack of exercise is one of the
most common causes of chronic diseases, making patients more
susceptible to infections and complicating disease courses (104,
105). Evidence on preventive effects of exercise for the elderly is
overwhelmingly positive (106). CIM exercises offers a range of
preventive possibilities that may also include MBM approaches
(91, 92, 107–109). Exercise practiced in open air such as Nordic-
walking or a walk in the forest may have greater overall positive
effects than fitness training in a studio or indoor home situations
(110, 111).
Nature and Forest Therapy
Spending time in nature can be both a preventive and a
therapeutic approach that makes use of targeted effects of
natural stimuli in forests, urban green spaces, and therapeutic
landscapes in order to promote health-related self-regulation
mechanisms in individuals and communities (15, 112). Nature
and forest therapy thus represent a simple, easily accessible, low-
cost, sustainable, and effective supportive method for improving
health parameters. Especially in the current pandemic nature
therapy can be important, because it can be practiced in the open
air and individually. Therefore, these measures will most likely
play an important role in preventive medicine in the near future
(113). Recent studies showed an overall stress-reducing effect on
quality of life, well-being, functions of the autonomic nervous
system, blood pressure, endocrine activity, happiness, mental
health, immune activity, and even neighborhood satisfaction
(114, 115). These are factors that could be valuable in the
current pandemic.
Aromatherapy
Closely related to nature and forest therapy is the field of
aromatherapy. Preclinical and clinical research on the effects
of certain bioactive compounds in essential oils, which are
available in a large number of plants, has gained a boost and is
increasingly published (116). Of particular interest are the effects
of terpenes and terpenoids on the suppression of inflammatory
and infection responses and the immunomodulatory properties
of these compounds (117). Aromatherapy has been explicitly
and/or implicitly part of CIM worldwide, particularly in the field
of botanical medicine, where such properties are used to achieve
specific therapeutic goals (118–120), for example to reduce
anxiety (121). Due to their anti-microbial portfolio, several of
these substances are of interest for the prevention of (respiratory)
infections, the supportive treatment of conventional treatments,
or a stand-alone CIM therapy in the case of a mild course of
respiratory tract infections (122).
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Sleep
Healthy sleep is undoubtedly an essential resource for health.
Sleep deficiency, poor sleep quality or shifts in the chronobiologic
sleep rhythm are associated with an increase in chronic diseases
(123). Insufficient sleep (<7 h) is also associated with a significant
increase in upper respiratory tract infections (105, 124, 125). CIM
offers a variety of ways to improve sleep duration and quality
including the application of oil mixtures of aromatherapy (126),
e.g., lavender, but also MBSR, yoga, and tai chi may improve
sleep quality (127). A small study showed that progressive muscle
relaxation might reduce anxiety and improve sleep quality in
patients isolated with COVID-19 (128).
Botanicals/Phytomedicine
The use of herbal substances for respiratory viral infections is
widespread and there are clinical data that may be relevant
during the current pandemic (8, 129). For the treatment of
viral infections of the upper respiratory tract, there are many
preclinical data available for individual components as well
as for entire plant extracts. A selection of promising herbal
medicines (Pelargonium root extract, Sambucus nigra, green Tea,
Glycyrrhiza, Echinacea species, Cistus incanus, Cannabinoids)
that may be relevant to the current COVID-19 pandemic are
presented below. A recent meta-analysis including 7 RCTs,
comprising a total of 732 adults, showed an advantage for
Chinese herbal medicine (CHM) compared to standard care (SC)
alone: CHM plus SC had a superior effect on the change of
symptom and sign score (−1.30 by SMD, 95% CI [−2.43,−0.16];
3 studies; n= 261, P= 0.03), on inflammatory marker C-reactive
protein (CRP, mg/L; −11.82 by MD, 95% CI [−17.95, −5.69];
5 studies; n = 325, P = 0.0002), on number of patients with
improved lung CT scans (1.34 by risk ratio, 95% CI [1.19, 1.51];
4 studies; n = 489, P < 0.00001) (130). No significant adverse
events were recorded in the included RCTs. Several ongoing RCTs
are investigating the effects of Chinese herbal medicine in the
treatment of COVID-19.
Pelargonium Root Extract
In traditional South African medicine, the root Umckaloabo
(from Pelargonium sidoides DC) has been the predominant
medicine for airways infections. Use and research in Western
countries have established its antibacterial and antiviral potential.
When tested in several conventional assays against 14 types
of viruses, it showed activity against e.g., parainfluenza virus,
influenza A virus (strains H1N1 and H3N2), human coronavirus,
but not against the avian influenza A virus (H5N1) (131). In
another model the ciliary beat frequency increased as a factor of
mucociliary clearance (132).
A systematic review of 8 RCTs using different extracts from
roots of Pelargonium sidoides in a variety of upper respiratory
tract infections showed moderate evidence in the treatment of
acute rhinosinusitis, colds in adults and in acute bronchitis in
children and adults (133). More recent reviews have confirmed
this when they were limited to colds (meta-analysis of 5 RCTs)
(134), and when they were limited to children and adolescents,
but allowed for various respiratory infections (meta-analysis
of 6 RCTs; narrative review of 8 RCTs) (135). The latter also
concluded symptom-alleviating effects in special situations such
as in asthmatic or immunocompromised children (136).
Sambucus Nigra
For centuries, TMS in Europe and North America have used
black elderberry (Sambucus nigra L.) for colds and influenza.
In-vitro activity against 18 strains of influenza was shown with
a syrup (137), while infected chimpanzees had better recovery
from influenza (138). In contrast to many other phytodrugs,
Sambucus nigra was already tested in at least two placebo-
controlled RCTs in times when no standard antiviral therapy
was available. They differed by about one decade and locations
(Israel and Norway, respectively), so different influenza strains
were predominant. The results were very similar, as the relief
of self-reported symptoms was accelerated by an average of
4 days. In both studies, syrup with a standardized content of
flavonoids, which was considered to be the active ingredient, was
administered (139, 140).
Green Tea
Catechins as a class of polyphenolic flavonoids are the main
active ingredients of green tea as well as many other teas,
which among other properties can strengthen the immunity
against viral, especially influenza infections (141). The most
prominent of these, epigallocatechin gallate (EGCG), even
inhibited dengue virus infection in vitro regardless of the serotype
and at concentrations reasonable for pharmacological application
(142). Several epidemiological studies have suggested that regular
consumption of green tea decreases influenza infection rates
(143), while clinical trials have mostly used standardized catechin
extracts. In one study, a cohort of low-risk health professionals
took 1,000 mg/d of standardized green tea catechins or placebo
over 150 days. The incidence of viral influenza was lowered by an
odds ratio of 0.25, at the same time duration of symptoms was
shorter (144).
In addition to optimizing systemic immune functions,
experiments have been carried out to investigate the effects of
gargling green tea to protect against the influenza virus at the
point of first contact with the human mucosa in the throat. The
pooled analysis of 5 RCTs gave a relative risk of 0.7 for the
incidence of influenza for green tea gargling as compared with
water gargling or no intervention (145).
Glycyrrhiza
Due to the lack of effective antiviral drugs, several phytodrugs
have been used for antiviral indications, mostly in prevention
and/or treatment of influenza and common cold (146).
The saponin glycyrrhizin either from Glycyrrhiza glabra
(Mediterranean world) or from Glycyrrhiza uralensis Fisher
(Eastern Asia) is considered to be the active component
of licorice roots used almost all over the world. Its
immunomodulatory and anti-inflammatory effects are well-
known. Mice infected with lethal doses of influenza virus
had much better chances of survival after having been given
glycyrrhizin (147). Uptake of influenza A virus into isolated
human lung cells and its intracellular replication were clearly
reduced, but only when the glycyrrhizin was given before
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infection (148). In spite of its frequently recommended use,
it has been tested in RCTs only as one of four components
of maoto, the most frequent formulation for influenza in
the traditional Japanese medicine “Kampo.” According to a
systematic review, it may decrease the duration of fever when
used alone or in combination with standard neuroaminidase
inhibitor therapies (149).
Echinacea Species
Numerous preparations of different parts and with different
extracts of Echinacea species, esp. purpurea L. and angustifolia L.
have been used for similar purposes as glycyrrhizin. A Cochrane
review revealed small advantages in reducing incidence and
course of common cold (150). A whole-plant hydroethanolic
extract from freshly pressed Echinacea purpurea was given in an
RCT to patients with proven influenza and was not inferior to
standard therapy with oseltamivir (151). A recent review showed
that study results were largely consistent with a decrease in
pro-inflammatory cytokines that play a role in the progression
of cytokine storm and ARDS. No studies are currently being
conducted on the therapeutic effect of echinacea in the treatment
of cytokine storm (152).
Cistus Incanus
In recent studies, promising anti-viral properties of the
traditional Mediterranean medicinal plant Cistus incanus (or
Cistus creticus) containing highly polymeric polyphenols as active
ingredients were established in preclinical (153) and animal
studies (154) in influenzamodels. However, clinical efficacy could
only be shown in one RCT with common cold (155).
Cannabinoids
Recently, with reference to the “cytokine storm” associated to
COVID-19, certain cannabinoids have also been discussed as
potentially useful in this context, based on immunomodulatory
properties associated to cannabinoids; however, the available
evidence is exclusively from the preclinical area and does not
allow any conclusions regarding potential effects of cannabinoids
in the context of acute viral infections (156).
Traditional Medicine Systems (TMS)
Many of the above presented aspects can be found as part of TMS.
TMS have a vast and diverse heritage from across the world and
the WHO defines TMS as an “essential resource in medical care”
(14).
At present, the majority of Chinese COVID-19 patients are
treated with Traditional Chinese Medicine (TCM) in addition to
conventional medicine within the framework of official medical
therapy strategies (157–159). Similar developments are currently
evolving in India with Traditional IndianMedicine (TIM) as well
(88, 90, 160).
The main mechanisms of action of TMS-based self-regulatory
approaches are mainly attributed to changes in diet and lifestyle
under preventive aspects (161). But TMS may also offer a variety
of defined supportive treatment measures for infectious diseases,
such as poly-herbal compound preparations (157, 158, 162).
Their effects are usually much more unspecific than, for example,
a targeted antiviral strategy tailored to individual virus subtypes.
The non-specificity of TMSmay indeed prove to be of advantage,
for a broader universal applicability with fewer adverse effects.
There are a number of protocols for systematic reviews and
meta-analyses in the field of TCM on various topics related
to COVID-19 associated diseases, the results of which are to
be published in the coming months (163–167). On the other
hand TCM may include products from rare wildlife, thus TCM
could act as a source of SARS-CoV-2 like novel viruses (168). In
response to the rapid spread of SARS-CoV-2 and the assumed
role of Chinese wildlife markets, the Chinese government issued
a temporary ban on the hunting, trade, and consumption of
numerous wildlife species in February 2020 (169). However, these
measures affect only part of the wildlife trade: the government
defined only certain wild animals as “special farm animals,” thus
exempting them from the trade ban (170). The wildlife ban only
applies to consumption, but not to use in TCM (169); this does
not account for the largely vegetarian-oriented TMS of South
Asia, for example Ayurveda (171).
General Recommendations
We have assembled a compendium of CIM recommendations
formulated for clinicians, patients and the healthy population for
general use, but these recommendations might be of particular
benefit to people during the current COVID-19 pandemic
(Figure 1 and Table 1).
DISCUSSION
The aim of this qualitative review was to summarize the available
evidence of CIM approaches with potential preventive and/or
therapeutic relevance to the current COVID-19 pandemic. No
SARS-CoV-2 specific claims are being made. Based on the
available data, CIM could support coping strategies that could be
helpful in dealing with the potential impact of public restriction
measures imposed by the pandemic on the health and well-being
of individuals and communities.
The relevance of CIM approaches in the COVID-19 pandemic
is based mainly on the following four aspects: (1) CIM can have
favorable effects on risk factors through lifestyle modifications
such as diet, stress reduction, exercise, and other means of self-
care (8, 158, 161), (2) CIM and especially MBM interventions
can have a positive effect on stress and psychological parameters
in a pandemic situation, particularly in the context of social
isolation, anxiety, and depression (100), (3) CIM can strengthen
the immune system in the case of non-communicable diseases
(NCD) and CD (173), (4) CIM may have antimicrobial effects
in case of targeted nutritional interventions and selected
phytomedicine (8). The fact that the mentioned approaches and
their mechanisms of action are not (yet) specific for SARS-CoV-2
and COVID-19 is not a convincing argument against the use of
selected CIM measures in this global crisis. When few scientific
data on effective and pathogen- and disease-specific preventive
or therapeutic choices are available, considering CIM tools may
be a wise response in our call for action during this pandemic.
Currently, no specific therapy for COVID-19 has shown to
be effective that has been tested in at least one convincing
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FIGURE 1 | Key aspects of CIM in strengthening mental and physical health during a pandemic.
TABLE 1 | Recommendations for patients.
Mind-Body Medicine and relaxation
Use the time available to encourage inner peace, contemplation, reflection, meditation (63). Maybe you can try out yoga, meditation, or other relaxation classes
online.
Strengthening relationships
Affection: Think of all those who are important in your life and what they mean to you in a positive sense. Exchange your thoughts with them and maintain
communication (103). Make phone calls or online calls. Allow yourself to express your affection and gratitude.
Support others: Call elderly people of your family and those who live on their own, entertain them by video calling, shop for others and just be there for them to
ease the loneliness of the quarantine (172).
Positive attitude
Focus your attention on positive aspects (94, 97): This lifts the spirits and strengthens resilience. Think about what you will do today that is beautiful and what
positive things you want to do in the future. Limit the amount of time you spend reading or watching news about the current crisis.
Humor and laughter (98): Even though the times are challenging, you can do things which makes you laugh or takes your mind off worrying. Read books which
are funny, watch funny movies, swap jokes.
Exercise
Do at least 15–30min a day of morning stretches, walking, jogging or any other activity which suits you (18). Think creatively to use the available space at home
such as, an open window, on the terrace, in the garden, a park, forest or wherever it is currently possible.
Eat and drink healthy (21)
Try to eat regularly, preferably while being seated. Eat at least one warm main meal a day, preferably freshly cooked. Use a variety of kitchen herbs and spices.
Drink plenty of water and incorporate warm drinks such as unsweetened herbal teas, ginger tea, teas with licorice, green tea into your diet. Drink small amounts of
elderberry juice if available.
• Chose fruits and vegetables with a range of colors. Eat plenty of fruit and vegetables, fresh or frozen, preferably organic.
• Bitter food (e.g., constituents found in radicchio, endive, chicory, chard, eggplant, olives)
• Food rich in vitamin C (e.g., found in parsley, peppers, cauliflower, turnip cabbage, broccoli, cress, lemon, oranges, Brussels sprouts, chives, sea buckthorn juice)
• Mustard oils (e.g., found in garlic, leek, onion, spring onion, cabbage)
• Herbs and spices (e.g., thyme, oregano, cloves, bay leaves, ginger, turmeric, basil, lemon balm, peppermint, rosemary, cinnamon—cook with them or prepare
tea with them)
• Integrate whole grain products and pulses.
• If you prefer snacks/sweets foods, choose dark chocolate, nuts and seeds, dates, sweet fruit, licorice, cold extracted (forest) honey.
• Reduce or avoid sugar and salt, highly glycemic foods and saturated fat (e.g., found in convenience food).
Sleep well
Long and restful sleep strengthens the immune system. Practice a good sleep hygiene with regular sleeping hours by turning off screens and keeping the room
cool, quiet and dark. If you feel cold, place a hot water bottle on your feet. Sleep for at least 7 h (127).
Nutritional supplements
Maybe you don’t need one. Most people can get all the vitamins and minerals they need through healthy eating. However, some people who do not get enough
vitamins and minerals from food alone, or who suffer from certain diseases, might benefit from taking supplements, e.g., vitamin D (49).
This list is only intended to help you identify lifestyle interventions that can strengthen your immune system. It is not intended to recommend any treatments, nor has any of them
been shown to be effective against COVID-19. None of these practices are intended to replace other recommended treatments. Always consult your doctor or health care provider
before starting.
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RCT. Even for initially promising drugs, the evidence so far
is negative (Hydroxychloroquine) or ambivalent (Remdesevir),
while worldwide research in this field are developing with
incredible urgency (174). In addition, proven preventive
strategies are limited to an inhibition of any contact that
facilitates virus transfer (175). Specific population groups at
particular risk are the elderly, and patients suffering from
COVID-19 with comorbidities such as chronic diseases like
hypertension, diabetes, lung diseases, cancer, rheumatism, or
autoimmune diseases. These population groups need strategies
to cope with the current crisis (7). There is no proven or
recommended strategy for people at risk to decrease their
susceptibility, or if infected improve course and outcome (33).
In addition, effective rehabilitation measures will be required for
COVID-19 intensive care survivors. Here as well, it is important
to identify specific and non-specific measures as well as their
possible additive contributions from the fields like nutrition,
physical exercise, phytomedicine, TMS, and MBM.
Another aim should be to improve immune functions
through sufficient availability of essential micronutrients to build
defense and physiological coping mechanisms, and to increase
regenerative functions. CIM approaches may be a way to attempt
delaying virus replication in the case of infection e.g., with
the aid of selected foods for which antiviral effects have been
demonstrated experimentally, though yet not for SARS-CoV-
2, or which may indirectly improve the immune defense by
reducing pathogens in other mucous membranes (such as the
intestine) since there many food compounds with potential
antiviral properties exist. Several different nutrients and vitamin
compounds and applications have been found to improve and
clean mucosal surfaces, thus interfering with viral replication on
the mucosal surface and improving tissue homeostasis during
viral replication and immune defense (132). For example, vitamin
C is particularly important in the metabolism of immune cells
and, as an antioxidant, is providing protection against collateral
damage to cells and tissues caused by oxygen radicals as part
of the immune defense. Regenerative processes in building and
maintaining connective tissue structures are also improved by
vitamin C, an effect that is gradually lost in scurvy, the vitamin
C deficiency disease (176).
As previously discussed, many of the CIMmeasures may have
the greatest effect in the field of prevention and strengthening
of coping mechanisms as well as reduce risk factors for severe
COVID-19 courses. However, CIM interventions could also help
in the situation of acute infections. For example, many of the
described substances are probably most effective when in direct
contact with the pathogen in sufficient concentration already
when consumed, such as when they can act as tea in the mouth
and the throat area (e.g., gargling with green tea), when they
act on the intestinal mucosa during digestion or when they are
released back to respiratory surfaces from the circulation after
absorption through the gut mucosa (e.g., garlic, ginger, thyme).
A significant positive effect of these foods could also be their
effect on the intestinal flora. The microbiome of the intestine is
strongly influenced by our diet. Particularly with poor nutrition
(rich in refined sugar, saturated fatty acids, animal protein,
fried and processed foods), the burden by increased scavenging
processes for macrophages and the stress to microbial metabolite
removal for the immune system can weaken the defense capacity
in acute infections. Therefore, a healthy, preferably plant-based
diet could be of additional importance as a basic component of
prevention (177–179).
Limitations of this non-systematic qualitative review include
(1) presentation of CIM interventions and substances to the
largest extend not (yet) tested on COVID-19 patients, (2)
uncertainty about the safety of such interventions in case
of COVID-19 infections, (3) uncertainty about which CIM
intervention might be most appropriate for the individual
patient, and (4) a non-systematic selection of CIM interventions.
Thus, publication biases could not be excluded. In addition,
most reported meta-analyses reported a very low to moderate
quality of evidence. Following reviews and clinical studies
should therefore systematically assess the safety of CIM
interventions, conduct methodologically high-quality CIM
studies in prevention and therapy of COVID-19 patient
symptoms and systematically review present and further
CIM interventions.
CONCLUSION
During the current COVID-19 pandemic, robust evidence for
effective prevention and specific therapy at the global level is
not yet available. To date, there is no clinical evidence of a CIM
measure to prevent or treat SARS-CoV-2-infection. Nevertheless,
action must now be taken to reduce the potential negative
impact of quarantine and physical distancing on human well-
being and to reduce the morbidity and mortality of COVID-19
(180). CIM holds a substantial potential for building resilience
and strengthening preventative resources through measures
such as changing lifestyle and diet, using herbs, improving
mental and physical health and reducing stress. In particular
the fields of botanical medicine and aromatherapy should be
subjects of further scientific attention and clinical research, as
it is known from substantial preclinical and limited clinical
research that many botanicals have properties that protect against
respiratory viruses.
CIM offers a variety of easily feasible, accessible, evidence-
based preventive, and therapeutic options for respiratory
infections and for strengthening physical and mental resilience,
likely to also help in prevention and treatment of COVID-19. An
increased and sustaining use of the preventive and therapeutic
potential of CIM in addition to the development of vaccination
and specific treatment strategies for COVID-19 seems plausible
and necessary. Although the amount of literature on CIM topics
is steadily increasing, this does not necessarily correspond to an
increase in high-quality evidence. Particularly, further clinical
research is needed, including methodologically high-quality
studies. Reviews should be continuously updated to provide a
balanced view of the available data. In summary, more scientific
work needs to be done to clarify the use of CIM interventions
in the prevention and treatment of COVID-19. However, the
implementation of potentially effective, safe and easily accessible
CIM measures should already be considered now. In addition,
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there is a need to identify unsubstantiated claims of CIM
measures with respect to SARS-CoV-2. All this would require
a national or supranational initiative to facilitate the necessary
substantial research to define possible contributions of CIM in
the COVID-19 pandemic and beyond.
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